501
TÍTULO: Therapeutics for Huntington's disease: a systematic review  Full Text
AUTORES: Mestre, TA; Ferreira, JJ; Coelho, M; Rosa, MM; Sampaio, C;
PUBLICAÇÃO: 2008, FONTE: 12th Congress of the European-Federation-of-Neurological-Societies in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 15
INDEXADO EM: WOS
502
TÍTULO: A 2-year open-label study of botulinum toxin type B in botulinum toxin type A resistant/responsive cervical dystonia patients (AN072-401 EUICD)  Full Text
AUTORES: Peter Moore; Joaquim Ferreira; Eric Pappert;
PUBLICAÇÃO: 2008, FONTE: 6th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins in TOXICON, VOLUME: 51
INDEXADO EM: WOS
NO MEU: ORCID
503
TÍTULO: Is treatment of cervical dystonia patients with botulinum toxin type B affected by a previous response to a botulinum toxin type A? Analysis of a long-term open-label study (AN072-401 EU/CD)  Full Text
AUTORES: Peter Moore; Joaquim Ferreira; Terry Germanson; Eric Pappert;
PUBLICAÇÃO: 2008, FONTE: 6th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins in TOXICON, VOLUME: 51
INDEXADO EM: WOS
NO MEU: ORCID
504
TÍTULO: Botulinum toxin type A (Botox) versus botulinum toxin type B (Myobloc) in subjects with cervical dystonia: A comparison of the frequency of xerostomia and dysphagia (AN072-402 EU/CD)  Full Text
AUTORES: Eric Pappert; Terry Germanson; Peter P Moore; Joaquim Ferreira;
PUBLICAÇÃO: 2008, FONTE: 6th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins in TOXICON, VOLUME: 51
INDEXADO EM: WOS
NO MEU: ORCID
505
TÍTULO: The effects of repeated dosing of botulinum toxin type B (neurobloc (R)) in patients with cervical dystonia previously naive to botulinum toxin: An open-label extension study (AN072-402 EU/CD)  Full Text
AUTORES: Joaquim Ferreira; Peter Moore; Eric Pappert;
PUBLICAÇÃO: 2008, FONTE: 6th International Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins in TOXICON, VOLUME: 51
INDEXADO EM: WOS
NO MEU: ORCID
506
TÍTULO: A double-blind, randomised, placebo-controlled trial to investigate the efficacy and safety of nebicapone in levodopa-treated Parkinson's disease patients with motor fluctuations
AUTORES: Ferreira, JJ; Rascol, O; Poewe, W; Sampaio, C; Rocha, F; Nunes, T; Almeida, L; Soares da Silva, P ;
PUBLICAÇÃO: 2008, FONTE: 12th International Congress of Parkinsons Disease and Movement Disorders in MOVEMENT DISORDERS, VOLUME: 23, NÚMERO: 1
INDEXADO EM: WOS
NO MEU: ORCID
507
TÍTULO: Hyposmia in G2019S LRRK2-related parkinsonism: Clinical and pathologic data
AUTORES: Silveira-Moriyama, L; Guedes, LC; Kingsbury, A; Ayling, H; Shaw, K; Barbosa, ER; Bonifati, V; Quinn, NP; Abou-Sleiman, P; Wood, NW; Petrie, A; Sampaio, C; Ferreira, JJ; Holton, J; Revesz, T; Lees, AJ;
PUBLICAÇÃO: 2008, FONTE: Neurology, VOLUME: 71, NÚMERO: 13
INDEXADO EM: CrossRef
NO MEU: ORCID
508
TÍTULO: miRNAs in human neurogenetics
AUTORES: Martins, MC; Rosa, A; Fonseca, BV; Violante, S; Guedes, LC; Mestre, T; Coelho, M; Rosa, MM; Ferreira, JJ; Oliveira, SA;
PUBLICAÇÃO: 2008, FONTE: CELLULAR ONCOLOGY, VOLUME: 30, NÚMERO: 3
INDEXADO EM: WOS
NO MEU: ORCID
509
TÍTULO: Prescribing habits of anti parkinsonian agents across Europe
AUTORES: Rosa, MM; Ferreira, JJ; Coelho, M; Freire, R; Sampaio, C;
PUBLICAÇÃO: 2008, FONTE: MOVEMENT DISORDERS, VOLUME: 23, NÚMERO: 1
INDEXADO EM: WOS
NO MEU: ORCID
510
TÍTULO: Botulinum toxin type B (MYOBLOC) in patients with cervical dystonia: An open-label extension study (AN072-402 EU/CD)
AUTORES: Ferreira, JJ; Moore, A; Pappert, E;
PUBLICAÇÃO: 2008, FONTE: NEUROLOGY, VOLUME: 70, NÚMERO: 11
INDEXADO EM: WOS
NO MEU: ORCID
Página 51 de 57. Total de resultados: 564.